Commercialization Committee

The Commercialization Committee shall be composed of at least 2 members, to be appointed from the Board members. The current members are Lauren Barnes (Chairman), Peter Benson and Hans Maier.

The Commercialization Committee is a preparatory organ within the Board with the main duties to:

  • prepare resolutions to be adopted by the Board pertaining to matters regarding overall commercialization plans and key commercialization decisions of products within Ascelia; and
  • oversee launch readiness; and
  • oversee that commercialization capabilities are available timely and adequately according to agreed plans.

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020